TrialCancer immunology, immunotherapy : CII2024

Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial.

Dan Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.